In a presentation given last Saturday at the annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Vienna, a Canadian research team introduced yet another potential test that may be helpful in differentiating between patients at relatively high or low risk for metastasis, based on biopsy tissue. A full report on this […]![]()
